152 results match your criteria: "Claudius Regaud Institute[Affiliation]"
Eur J Cancer
January 2025
Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Via Venenzian, 1, 20133 Milan, Italy.
Background: Rare cancers correspond to approximately 200 clinical entities, which can be grouped into 12 families. Updated data are available for childhood and haematological cancers, ie, for only two of the 12 families of rare cancer. We provide incidence and survival for the remaining ten families of rare adult solid cancers (RAC), across 29 EU Member States and over time.
View Article and Find Full Text PDFGlob Health Promot
November 2024
University of Bordeaux, INSERM, BPH, U1219, Mérisp/PHARES Equipe Labellisée Ligue Contre le Cancer, Bordeaux, France.
This article explores the role of population health intervention research (PHIR) in enhancing health promotion in France, stressing the importance of a more in-depth understanding and thorough analysis of healthcare interventions. Established in 2022, the So-RISP network aims to structure the PHIR field, consolidating expertise from renowned teams specializing in PHIR, primary cancer prevention, and addiction. In January 2023, So-RISP members convened a national workshop.
View Article and Find Full Text PDFEur J Surg Oncol
October 2024
Digestive Cancer Registry of Burgundy, Dijon, France; French Network of Cancer Registries (FRANCIM), France; Dijon University Hospital, Dijon, France; INSERM UMR 1231, EPICAD, Dijon, France; Université de Bourgogne, Dijon, France. Electronic address:
Introduction: Surgical resection is the standard recommended treatment in localized pancreatic cancer. The benefit of neoadjuvant chemotherapy is still debated. The aim of this population-based study was to describe the pancreatic cancer surgical management.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
September 2024
Department of Dermatology, Nantes Université, CHU Nantes, Nantes, France.
Haematologica
September 2024
INSERM UMR1037, CNRS UMR5071, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France; Laboratoire d'Excellence 'TOUCAN-2', Toulouse.
Not available.
View Article and Find Full Text PDFGynecol Oncol
November 2024
Department of Obstetrics, Gynecology and Neonatology First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague 128 08, Czech Republic.
Introduction: Fertility-sparing treatment (FST) for patients with cervical cancer intends to achieve oncologic outcomes comparable to those after radical treatment while maximizing reproductive outcomes, including the ability to conceive and minimizing the risk of prematurity.
Methodology: International multicentre retrospective FERTISS study focused on patients treated with FST analysed timing of FST relative to pregnancy, conception attempts and methods, abortion rates, prophylactic procedures reducing the risk of severe prematurity, pregnancy duration, and delivery mode.
Results: Of the 733 patients treated at 44 centres in 13 countries, 49.
Bladder Cancer
June 2024
Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Background: Prognostic tools in pathological-node (pN) patients after radical cystectomy (RC) are needed.
Objectives: To evaluate the prognostic impact of lymph node (LN)-density on disease-specific survival (DSS) in patients with bladder cancer (BC) undergoing RC with pelvic lymph node dissection.
Methods: We analyzed a multi-institutional cohort of 1169 patients treated with upfront RC for cT1-4aN0M0 urothelial BCat nine centers.
J Eur Acad Dermatol Venereol
August 2024
Oncodermatology Clinic, Hospital Ruber Juan Bravo and Universidad Europea, Madrid, Spain.
ESMO Open
August 2024
The Unit of Molecular Pathology, INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, and Team Genetics, Epigenetics and Biology of Sarcomas, Université Claude Bernard Lyon 1, Lyon; Department of Biopathology, CNR MESOPATH NETMESO, CLCC UNICANCER Leon Berard, Lyon; University Grenoble Alpes, Grenoble, France.
Background: Mesothelioma is a rare and aggressive malignant neoplasm arising from mesothelial cells, which occasionally manifests recurrent fusions. EWSR1/FUS-CREB, YY1, MAP3K8, NR4A3, and ALK-rearranged proliferations have been reported in limited series with no clear histological or clinical correlations, limiting clinicians' ability to assess prognosis and integrate these new entities into therapeutic decisions. The aim of this study was to better characterize these rearranged proliferations histologically, molecularly, and clinically.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
July 2024
Medical Direction Dermo-Cosmétique & Personal Care, Pierre Fabre Group, Toulouse, France.
Head Neck
December 2024
Department of Surgery, University Cancer Institute of Toulouse - Oncopole, Toulouse, France.
Objective: To elucidate the prognostic implications of mucosal and deep margin distances in oral tongue squamous cell carcinoma (OTSCC), and to assess a different margin cut-off value in T1-T2 versus T3-T4 tumors.
Methods: This single-center retrospective study included 223 patients who received surgery for a primary OTSCC between January 2017 and December 2021.
Results: Multivariable analysis showed that deep margin distance ≥3 mm in T1-T2 tumors and ≥5 mm in T3-T4 tumors was significantly associated with better RFS and OS.
ESMO Open
June 2024
Institut Curie, Institut du Thorax Curie-Montsouris, Paris & St Cloud, France. Electronic address:
Purpose: The RAS/MEK signaling pathway is essential in carcinogenesis and frequently altered in non-small-cell lung cancer (NSCLC), notably by KRAS mutations (KRASm) that affect 25%-30% of non-squamous NSCLC. This study aims to explore the impact of KRASm subtypes on disease phenotype and survival outcomes.
Patients And Methods: We conducted a retrospective analysis of the French Epidemiological Strategy and Medical Economics database for advanced or metastatic lung cancer from 2011 to 2021.
Neurooncol Adv
May 2024
Service de Neuro-Oncologie, Institut de Neurologie, DMU Neurosciences, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Background: Oncogenic FGFR-TACC fusions are present in 3-5% of high-grade gliomas (HGGs). Fexagratinib (AZD4547) is an oral FGFR1-3 inhibitor with preclinical activity in FGFR-TACC+ gliomas. We tested its safety and efficacy in patients with recurrent FGFR-TACC + HGGs.
View Article and Find Full Text PDFBMC Cancer
April 2024
Department of Pulmonology and Thoracic Oncology, North West Hospital of Villefranche, Villefranche, France.
Background: We designed this study based on both a physician practice survey and real-world patient data to: (1) evaluate clinical management practices in extensive-stage small cell lung cancer (ES-SCLC) among medical centers located across France; and (2) describe first-line treatment patterns among patients with ES-SCLC following the introduction of immunotherapy into clinical practice.
Methods: A 50-item questionnaire was completed by physicians from 45 medical centers specialized in SCLC management. Responses were collected from June 2022 to January 2023.
BMC Public Health
January 2024
EQUITY research team (Certified by the French League Against Cancer), CERPOP, UMR 1295, Université Toulouse III Paul Sabatier, Toulouse, France.
Background: With the increase in the number of long-term survivors, interest is shifting from cancer survival to life and quality of life after cancer. These include consequences of long-term side effects of treatment, such as gonadotoxicity. Fertility preservation is becoming increasingly important in cancer management.
View Article and Find Full Text PDFDig Liver Dis
June 2024
Digestive Cancer Registry of Burgundy, Dijon, France; Dijon University Hospital, Dijon, France; INSERM UMR 1231 EPICAD, Dijon, France; University of Burgundy, Dijon, France; FRANCIM Network, Toulouse F-31073, France. Electronic address:
Aim: Real-life estimations of survival by stage in colorectal cancer are scanty. We estimated population-based net survival by pathological stage and location, and for rectal cancer by patterns of evolution according to clinical and pathological stage with regard to neoadjuvant therapy.
Method: Age-standardized net survival was estimated on 19,630 colorectal cancers diagnosed between 2009 and 2015.
Dermatol Ther (Heidelb)
December 2023
Center for Chronic Pruritus, Department of Dermatology, University Hospital Münster, Münster, Germany.
Introduction: Pruritus is a prevalent symptom, described as one of the most bothersome of psoriasis. Specific itch management remains a challenge, for which hydrotherapy could be used as adjunct care to medical treatment. Therefore, we assessed the immediate and longer-term benefit of 3 weeks of Avène thermal spring water hydrotherapy on chronic pruritus in patients in addition to their usual psoriasis and/or pruritus management.
View Article and Find Full Text PDFTurk J Anaesthesiol Reanim
August 2023
French Association on Human Factors in Healthcare, Paris, France.
The recent health crisis has increased the workload and the stress levels of healthcare professionals around the world. Such stressful working environments are conducive to an increased incidence of medical errors. Implementing education and training specifically focused on human and organizational factors can promote teamwork and decrease the risk of error.
View Article and Find Full Text PDFAnn Dermatol Venereol
September 2023
UOC Dermatologia, Fondazione Policlinico Universitario A.Gemelli-IRCCS, L.go Agostino Gemelli 8, 00168 Rome, Italy.
Biochem Pharmacol
August 2023
I2MC, Institut National de la Santé et de la Recherche Médicale (INSERM) U1297, University of Toulouse 3, Toulouse, France. Electronic address:
Obesity (Silver Spring)
July 2023
Radiation Epidemiology Team, Inserm U1018, Villejuif, France.
Objective: The aim of this study was to identify risk factors for obesity in childhood cancer survivors (CCSs).
Methods: The study included 3199 patients of the French Childhood Cancer Survivor Study cohort, with 303 patients with obesity who had returned the self-questionnaire. Analyses were adjusted for social deprivation index and sex.
Eur Arch Otorhinolaryngol
October 2023
Department of Surgery, University Cancer Institute of Toulouse - Oncopole, 1 Avenue Irène Joliot-Curie, 31100, Toulouse, France.
Purpose: Despite sharing the same staging system as oral cavity cancers, upper gingiva and hard palate (UGHP) squamous cell carcinoma (SCC) have several features that make them a different entity. We aimed to analyze oncological outcomes and adverse prognostic factors of UGHP SCC, and assess an alternate T classification specific to UGHP SCC.
Methods: Retrospective bicentric study including all patients treated by surgery for a UGHP SCC between 2006 and 2021.
Front Oncol
April 2023
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Eur J Surg Oncol
August 2023
Department of Surgery, University Cancer Institute of Toulouse - Oncopole, Toulouse, France. Electronic address:
Objective: to compare the rate of occult contralateral neck metastases (OCNM) in oral and oropharyngeal squamous cell carcinomas (SCC) reaching or crossing the midline and to identify risk factors for OCNM.
Materials And Methods: we conducted a single-center retrospective study of oral and oropharyngeal SCC with contralateral cN0 neck. The cohort was divided into a midline-reaching (MR; approaching the midline from up to 10 mm) group and a midline-crossing (MC; exceeding the midline by up to 10 mm) group.
Surg Radiol Anat
May 2023
Department of Gynaecological Surgery, University Hospital of Toulouse, Rangueil, Toulouse, France.
Purpose: Lymph node involvement in cancer of the uterine cervix is a major independent prognostic factor for overall survival. The aim of our study was to examine the lymphatic drainage regions of the different parts of the uterine cervix.
Methods: An anatomical study of fresh cadavers was conducted by injecting patent blue in the anterior or posterior lip of the uterine cervix and dissecting drainage regions.